Background and Objective: Miswak is a natural tooth cleaning tool which is being used in many parts of the world since ancient times. It is known to be useful in prevention of dental caries. But still it is not used as frequently as other oral hygiene tools. This research was designed to scientifically establish antimicrobial effect of miswak in vitro against common oral pathogens. Methods: This was a cross-sectional study involving 100 health care workers. This research was carried out in Microbiology section of Dow Diagnostic Research & Reference Laboratory. A questionnaire was designed to test oral hygiene habits of study subjects. Oral swabs were taken and microorganisms were identified by standard bacteriological methods. Test material included four different types of miswaks i.e. (1) root of the peelu (Salvadora persica) tree (in packing) (2) root of the peelu tree (without packing) (3) stem of the peelu tree & (4) stem of the neem (Azadirechta indica) tree. These miswaks were tested against three different types of microorganisms isolated from oral swabs: Staphylococcus aureus, Streptococcus mutans & Candida albicans by agar diffusion method. Inhibition zone was measured after 24 hrs of incubation at 37oC. Results: Among the miswaks used, root of the peelu tree in both packing and without packing exhibited strong antimicrobial effect against all three tested microorganisms. However miswak taken from the stem of the peelu and neem tree did not show any antimicrobial activity against all three types of the tested microorganisms. Conclusion: Miswak taken from the root of the peelu tree exhibited antimicrobial activity against all the common oral pathogens and could be a good oral hygiene tool in combating dental caries.
Objective: To find out the antibacterial susceptibility pattern of bacteraemia isolates of Salmonella enterica serovar typhi and paratyphi. Method: The retrospective descriptive observational study was conducted at the Microbiology section of Dow Diagnostic Research and Reference Laboratory, and comprised blood culture reports from January 1, 2017, to Dec 30, 2020, which were screened for the presence of Salmonella typhi and paratyphi growth The frequency of the isolates and their antibiotic resistance patterns were analysed. Data was analysed using SPSS 20. Results: Of the 174,190 blood culture samples, 62,709(36%) were positive for bacterial growth. Salmonella were isolated in 8,689(13.8%) samples of which 8,041(92.5%) were Salmonella typhi, 529(6%) were Salmonella paratyphi A and 119(1.3%) were Salmonella paratyphi B. There was a drastic increase in resistance to third-generation cephalosporin in Salmonella typhi from 71(12.8%) in 2017 to 1,420(71%) in 2018, 2,850(74.6%) in 2019 and 1,251(77%) in 2020. All isolates were sensitive to meropenem and azithromycin. Conclusion: A high number of extensively drug-resistant typhoid cases due to Salmonella typhi were found. All isolates were sensitive to meropenem and azithromycin. Key Words: Salmonella typhi, Multidrug resistance, Extensively drug-resistant.
ObjectiveThe present study is designed to monitor antibiotic susceptibility pattern of Escherichia coli to assist in forecasting empirical therapy of urinary tract infection.MethodologyIt is a retrospective cross sectional study. It was carried out at Dow Diagnostic Research and Reference Laboratory for a period of 3 months from February 2017 to April 2017. A data of total 5000 urine culture and sensitivity test reports was taken from the medical record. The data was analyzed by SPSS version 16.ResultsOut of 5000 urine samples processed, 1565 showed significant bacterial growth. Escherichia coli was the most common pathogen isolated. Meropenem, Amikacin, Fosfomycin and Nitrofurantoin respectively were found to be the most sensitive antibiotics against Escherichia coli.Conclusion Fosfomycin and Nitrofurantoin are effective oral antibiotics against Escherichia coli causing urinary tract infection. The present study may help clinicians in making rational choice of empirical treatment of the patients.
Background: Snake biting are a substantially neglected health problem in rural areas of Pakistan. There is a need for producing larger and better quality anti-snake venom to decrease mortality associated with snakebite cases. Objectives: The current study aimed to evaluate the efficacy of a novel strategy to produce antivenom against the venom of two common krait species found in Sindh, Pakistan Methods: This was an animal-based research conducted at Dow University of Health Sciences, Karachi, Sindh, Pakistan. All experimental subjects were categorized equally into two groups with unique numerals for identification purposes. i.e. Group A for Bungarus sindanus and Group B for Bungarus caeruleus. Each group consisted of 6 horses. One horse in each group acted as a control. Before initiating the immunization process, baseline serums were collected from the subject’s jugular veins and stored as baseline controls. Post immunization serums were weekly collected from the horses and stored. Enzyme-linked immunosorbent assay (ELISA) was used to estimate immunoglobulin of the subjects by adding a fixed amount of venom antigen with coating buffer pH of 9.5 to 10 ng, 100 ng, and 1000 ng. Incubated overnight at 37° C temperature in the incubator. Results: The results showed that the two species of the krait family did not show significant neutralizing antibodies against each other. The novel oral adjuvant formulation of snake venoms is safe and easy to administer which will be useful for commercial ASV production of potent antibodies at a significantly reduced cost and without any significant adverse effects on equine health. Conclusions: The current study presents an effective novel approach for the production of anti-snake venom for Bungarus sindanus and Bungarus caeruleus.
Objective: To determine the frequent bacterial pathogens causing blood stream infections in various age brackets, and to discover their antibiotic susceptibility pattern. Method: The retrospective, descriptive, observational, cross-sectional study was conducted at the microbiology laboratory of Patel Hospital, Karachi, and comprised positive blood culture bacterial isolates analysed between July 1, 2018, and June 30, 2019. Standard microbiological techniques were employed for the identification and antimicrobial susceptibility testing. Data was analysed using SPSS 20. Results: Of the 3450 specimen, 1243(36%) were positive; 668(53.7%) from male and 575(46.3%) from female subjects, and gram-positive 771(62%) and gram-negative 472(38%). Salmonella typhi was the most common pathogen 139(11.1) among gram-negative organisms, followed by acinetobacter species 103(8.2%), escherichia coli 96(7.7%) and klebsiella species 42(3.4%). Among gram-positive bacteria, the predominant isolates were staphylococcus epidermidis 650(52%), staphylococcus aureus 67(5.4%) and enterococci 28(2.3%). Linezolid (99.8%), vancomycin (99%) and chloramphenicol (69%) were found to be the most sensitive antibiotics among gram-positive cocci. Meropenem (60%), amikacin (46%) and gentamicin (40%) were the most sensitive antibiotics for multidrug resistant gram-negative bacteria. Conclusion: The identification of frequent bacterial pathogens in blood cultures of patients may guide clinicians in proper empirical selection of antibiotics in patients with bacteremia. Key Words: Blood stream infection, BSI, Antibiotic susceptibility, AST, Bacteriological profile, Multi-drug resistance, MDR.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.